Your browser doesn't support javascript.
loading
Application of a Scavenger Receptor A1-Targeted Polymeric Prodrug Platform for Lymphatic Drug Delivery in HIV.
Stevens, David M; Adiseshaiah, Pavan; Dasa, Siva S K; Potter, Tim M; Skoczen, Sarah L; Snapp, Kelsie S; Cedrone, Edward; Patel, Nimit; Busman-Sahay, Kathleen; Rosen, Elias P; Sykes, Craig; Cottrell, Mackenzie; Dobrovolskaia, Marina A; Estes, Jacob D; Kashuba, Angela D M; Stern, Stephan T.
Affiliation
  • Stevens DM; Nanotechnology Characterization Lab, Frederick National Laboratory for Cancer Research sponsored by the National Cancer Institute, Frederick, Maryland 21702-1201, United States.
  • Adiseshaiah P; Nanotechnology Characterization Lab, Frederick National Laboratory for Cancer Research sponsored by the National Cancer Institute, Frederick, Maryland 21702-1201, United States.
  • Dasa SSK; Nanotechnology Characterization Lab, Frederick National Laboratory for Cancer Research sponsored by the National Cancer Institute, Frederick, Maryland 21702-1201, United States.
  • Potter TM; Nanotechnology Characterization Lab, Frederick National Laboratory for Cancer Research sponsored by the National Cancer Institute, Frederick, Maryland 21702-1201, United States.
  • Skoczen SL; Nanotechnology Characterization Lab, Frederick National Laboratory for Cancer Research sponsored by the National Cancer Institute, Frederick, Maryland 21702-1201, United States.
  • Snapp KS; Nanotechnology Characterization Lab, Frederick National Laboratory for Cancer Research sponsored by the National Cancer Institute, Frederick, Maryland 21702-1201, United States.
  • Cedrone E; Nanotechnology Characterization Lab, Frederick National Laboratory for Cancer Research sponsored by the National Cancer Institute, Frederick, Maryland 21702-1201, United States.
  • Patel N; Small Animal Imaging Program, Frederick National Laboratory for Cancer Research sponsored by the National Cancer Institute, Frederick, Maryland 21702-1201, United States.
  • Busman-Sahay K; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon 97006, United States.
  • Rosen EP; Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States.
  • Sykes C; Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States.
  • Cottrell M; Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States.
  • Dobrovolskaia MA; Nanotechnology Characterization Lab, Frederick National Laboratory for Cancer Research sponsored by the National Cancer Institute, Frederick, Maryland 21702-1201, United States.
  • Estes JD; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon 97006, United States.
  • Kashuba ADM; Division of Pathobiology & Immunology, Oregon National Primate Research Center, Oregon Health & Science University, Portland, Oregon 97239, United States.
  • Stern ST; Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States.
Mol Pharm ; 17(10): 3794-3812, 2020 10 05.
Article in En | MEDLINE | ID: mdl-32841040

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Carriers / HIV Infections / Anti-HIV Agents / Scavenger Receptors, Class A Limits: Animals / Female / Humans / Male Language: En Journal: Mol Pharm Journal subject: BIOLOGIA MOLECULAR / FARMACIA / FARMACOLOGIA Year: 2020 Document type: Article Affiliation country: United States Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Carriers / HIV Infections / Anti-HIV Agents / Scavenger Receptors, Class A Limits: Animals / Female / Humans / Male Language: En Journal: Mol Pharm Journal subject: BIOLOGIA MOLECULAR / FARMACIA / FARMACOLOGIA Year: 2020 Document type: Article Affiliation country: United States Country of publication: United States